Pituitary adenoma surgery

Pituitary adenoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Pituitary adenoma from other Diseases
Epidemiology and Demographics
Risk Factors
Natural history, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Pituitary adenoma surgery On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Pituitary adenoma surgery All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pituitary adenoma surgery
CDC on Pituitary adenoma surgery
Pituitary adenoma surgery in the news
Blogs on Pituitary adenoma surgery
Directions to Hospitals Treating Pituitary adenoma
Risk calculators and risk factors for Pituitary adenoma surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]

Overview

The transsphenoidal microsugrical approach is the mainstay of treatment for growth hormone-(GH) producing adenomas, adrenocorticotropic hormone-(ACTH) producing adenomas, and macroadenomas.

Surgery

Surgical treatment for pituitary adenoma:

• Rapid deterioration of vision is considered as an immediate indication for surgery to relieve pressure produced by an expanding tumor mass.
• The transsphenoidal microsurgical approach to a pituitary lesion is the most widely employed surgical approach to pituitary lesions and represents a major development in the safe surgical treatment of both hormonally active and nonfunctioning tumors.
• This approach is often successful in debulking tumors, even those that have a significant suprasellar extension (without hourglass-shape appearance).

Contraindications to transsphenoidal microsurgical approach include:

• Tumors with a significant suprasellar extension with an hourglass-shaped narrowing between the intrasellar and suprasellar component, blind attempts to reach the suprasellar tumor may lead to cerebral damage.
• An infection in the sphenoid sinus

Craniotomies via a pterional or subfrontal approach may be performed if transsphenoidal microsurgical approach is contraindicated.